Dyadic International has expanded its bio-industrial pipeline with a new proprietary enzyme program focused on advanced cellulose processing, building on the success of its EN3ZYME™ product. This initiative leverages Dyadic's Dapibus™ platform to streamline development and manufacturing, targeting applications like pulp biorefining and nanocellulose production. The move taps into a growing multi-billion-dollar industrial enzyme market driven by demand for cost-effective, eco-friendly alternatives to chemical processes. Dyadic plans to commercialize through product sales, partnerships, and licensing, aiming to diversify revenue and support long-term growth.
NEAR Protocol (NEAR) has reportedly returned to the Bitwise 10 Crypto Index ETF, a product separate from Bitwise's U.S. spot NEAR fund. The Bitwise NEAR ETF (NRR), a U.S. spot fund, began trading on NYSE Arca on September 29 and held nearly $87 milli...
Kaspa (KAS) is available for purchase in Germany on three exchanges—Bitvavo, Kraken, and Bitpanda—all authorized under the EU's MiCA regulation. Prices for €100 of KAS are similar across Bitvavo and Kraken, but fees vary, with Bitvavo offering the lo...
Tether's Q3 2026 report shows assets exceeding liabilities by $7.95 billion, up from $4.1 billion in Q2, indicating a stronger reserve buffer. This coverage ratio of 104.3% means every dollar of liability is backed by $1.043 in assets, mainly US Trea...
Chainlink's reserve increased its holdings by 427,577 LINK tokens during October, worth more than $5.3 million, bringing the total to approximately 6.47 million LINK. This accumulation reflects the conversion of offchain enterprise revenue and onchai...
Threshold Network has paused new Bitcoin deposits, tBTC minting, and redemption requests to perform security maintenance. Despite this pause, holders can still use, transfer, and hold tBTC tokens already in circulation. Aave also froze its tBTC reser...
